JOHN L. LAMATTINA

Insider Reports History

Location
Waltham, MA
Signature
By: Andrew Reardon, Attorney-in-Fact For: John L. LaMattina
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JOHN L. LAMATTINA:

Company Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Director Common Stock 30,724 $6,312,245 $205.45 07 Nov 2025 Direct
Immunome Inc. Director Common Stock 66,953 $395,692 $5.91 15 Jan 2023 Direct
Immunome Inc. Director Stock Option (Right to Buy) 6,500 08 Jun 2023 Direct
LIGAND PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 0 07 Nov 2025 Direct

Insider Reports Filed by JOHN L. LAMATTINA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LGND LIGAND PHARMACEUTICALS INC 07 Nov 2025 6 -$575,343 4 Director 12 Nov 2025, 16:44
LGND LIGAND PHARMACEUTICALS INC 06 Jun 2025 2 $0 4 Director 10 Jun 2025, 19:24
LGND LIGAND PHARMACEUTICALS INC 27 Nov 2024 3 -$171,668 4 Director 02 Dec 2024, 20:05
LGND LIGAND PHARMACEUTICALS INC 14 Jun 2024 2 $0 4 Director 18 Jun 2024, 21:27
LGND LIGAND PHARMACEUTICALS INC 09 Jun 2023 2 $0 4 Director 13 Jun 2023, 18:55
IMNM Immunome Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:54
IMNM Immunome Inc. 15 Jan 2023 1 +$60,500 4 Director 17 Jan 2023, 05:29
LGND LIGAND PHARMACEUTICALS INC 22 Dec 2022 1 $0 4 Director 27 Dec 2022, 17:28
IMNM Immunome Inc. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 18:01
LGND LIGAND PHARMACEUTICALS INC 10 Jun 2022 2 $0 4 Director 13 Jun 2022, 18:45
LGND LIGAND PHARMACEUTICALS INC 16 Nov 2021 3 -$626,409 4 Director 17 Nov 2021, 16:06
LGND LIGAND PHARMACEUTICALS INC 04 Jun 2021 2 $0 4 Director 07 Jun 2021, 21:24
IMNM Immunome Inc. 28 May 2021 1 $0 4 Director 01 Jun 2021, 20:01
IMNM Immunome Inc. 24 May 2021 2 +$101,028 4 Director 26 May 2021, 21:26